---
title: 'Optimizing the Prediction of Depression Remission: A Longitudinal Machine
  Learning Approach'
date: '2024-10-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39470297/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241029183704&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Decisions about when to change antidepressant treatment are complex and
  benefit from accurate prediction of treatment outcome. Prognostic accuracy can be
  enhanced by incorporating repeated assessments of symptom severity collected during
  treatment. Participants (n = 714) from the Genome-Based Therapeutic Drugs for Depression
  study received escitalopram or nortriptyline over 12 weeks. Remission was defined
  as scoring ≤ 7 on the Hamilton Rating Scale. Predictors included demographic, clinical,
  ...
disable_comments: true
---
Decisions about when to change antidepressant treatment are complex and benefit from accurate prediction of treatment outcome. Prognostic accuracy can be enhanced by incorporating repeated assessments of symptom severity collected during treatment. Participants (n = 714) from the Genome-Based Therapeutic Drugs for Depression study received escitalopram or nortriptyline over 12 weeks. Remission was defined as scoring ≤ 7 on the Hamilton Rating Scale. Predictors included demographic, clinical, ...